Boston Scientific receives safety approval for deep brain stimulation product

News

Author: Parkinson's Life editorsPublished: 22 December 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Vercise Deep Bain Stimulation System

Medical manufacturer Boston Scientific has received approval from the U.S. Food and Drug Administration for the Vercise Deep Brain Stimulation System, a device engineered to customise therapy for people living with Parkinson’s.

The approval was based on the INTREPID study, a test that evaluated the safety and effectiveness of the system on 292 people with Parkinson’s.

The first commercial implant is scheduled to take place at the University of Minnesota Medical Center, US, by a team of faculty professionals.

Dr Jerrold Vitek, professor of neurology at the University of Minnesota, said: “The Vercise Deep Brain Stimulation System changes the landscape of what physicians can do to help improve the quality of life for people living with Parkinson’s disease.

“This system provides an ability to sculpt the current field in the deep brain stimulation target using novel technology that offers flexibility in programming.”

Go Back

Share this story

Comments


  • https://www.linkedin.com/today/author/134569387 Lisa Vanderburg

    At last – this will be so welcome particularly in the US where inferior devices and programming deficiencies have monopolized the market for way too long. Very happy to see this!

  • Rasha ElKholy

    How much it costs?

Related articles


Hungary lead

Global update

How the world is commemorating Parkinson’s Awareness Month

Parkinson’s Awareness Month 2016 round-up

READ MORE

Europe

High-profile MEP supports European inventory research initiative

EPDA launches new My PD Journey research project

READ MORE
parkinsons-film-still-lead-edited

Resources & Tools

VIDEO: “Children shouldn’t feel isolated or hopeless because a parent has Parkinson’s”

New educational film to support families dealing with Parkinson’s

READ MORE